Page last updated: 2024-10-28

hydroxychloroquine and Cardiomyopathy, Restrictive

hydroxychloroquine has been researched along with Cardiomyopathy, Restrictive in 6 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Cardiomyopathy, Restrictive: A form of CARDIAC MUSCLE disease in which the ventricular walls are excessively rigid, impeding ventricular filling. It is marked by reduced diastolic volume of either or both ventricles but normal or nearly normal systolic function. It may be idiopathic or associated with other diseases (ENDOMYOCARDIAL FIBROSIS or AMYLOIDOSIS) causing interstitial fibrosis.

Research Excerpts

ExcerptRelevanceReference
"We report two cases of hydroxychloroquine-induced hyperpigmentation presenting in a 50-year-old Caucasian female (case 1) and a 78-year-old female (case 2), both receiving 400 mg per day."7.74Hydroxychloroquine-induced hyperpigmentation: the staining pattern. ( Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W, 2008)
"We report two cases of hydroxychloroquine-induced hyperpigmentation presenting in a 50-year-old Caucasian female (case 1) and a 78-year-old female (case 2), both receiving 400 mg per day."3.74Hydroxychloroquine-induced hyperpigmentation: the staining pattern. ( Ferringer, T; Lountzis, NI; Puri, PK; Tyler, W, 2008)
"Hydroxychloroquine was discontinued, and follow-up echocardiogram 57 days after discontinuation showed normalization of her left ventricular ejection fraction."2.55Restrictive Cardiomyopathy Associated With Long-Term Use of Hydroxychloroquine for Systemic Lupus Erythematosus. ( Cox, ZL; Mendes, LA; Sabato, LA, 2017)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Lodge, FM1
Moody, WE1
Tosounidou, S1
Chue, CD1
Curtis, E1
Neil, DAH1
Bradlow, W1
Layoun, ME1
Desmarais, J1
Heitner, SB1
Masri, A1
Sabato, LA1
Mendes, LA1
Cox, ZL1
Puri, PK1
Lountzis, NI1
Tyler, W1
Ferringer, T1
Manohar, VA1
Moder, KG1
Edwards, WD1
Klarich, K1
Cotroneo, J1
Sleik, KM1
Rene Rodriguez, E1
Klein, AL1

Reviews

1 review available for hydroxychloroquine and Cardiomyopathy, Restrictive

ArticleYear
Restrictive Cardiomyopathy Associated With Long-Term Use of Hydroxychloroquine for Systemic Lupus Erythematosus.
    Journal of pharmacy practice, 2017, Volume: 30, Issue:5

    Topics: Aged; Antimalarials; Cardiomyopathy, Restrictive; Drug Administration Schedule; Female; Humans; Hydr

2017

Other Studies

5 other studies available for hydroxychloroquine and Cardiomyopathy, Restrictive

ArticleYear
Hydroxychloroquine-induced cardiomyopathy accelerated after gastric banding.
    Lancet (London, England), 2021, 11-20, Volume: 398, Issue:10314

    Topics: Antirheumatic Agents; Cardiomyopathy, Restrictive; Echocardiography; Female; Gastroplasty; Heart; Hu

2021
Hot hearts on bone scintigraphy are not all amyloidosis: hydroxychloroquine-induced restrictive cardiomyopathy.
    European heart journal, 2020, 07-01, Volume: 41, Issue:25

    Topics: Amyloidosis; Cardiomyopathies; Cardiomyopathy, Restrictive; Humans; Hydroxychloroquine; Radionuclide

2020
Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
    Journal of cutaneous pathology, 2008, Volume: 35, Issue:12

    Topics: Aged; Antacids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents

2008
Restrictive cardiomyopathy secondary to hydroxychloroquine therapy.
    The Journal of rheumatology, 2009, Volume: 36, Issue:2

    Topics: Antirheumatic Agents; Cardiomyopathy, Restrictive; Echocardiography; Female; Heart; Humans; Hydroxyc

2009
Hydroxychloroquine-induced restrictive cardiomyopathy.
    European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 2007, Volume: 8, Issue:4

    Topics: Antirheumatic Agents; Cardiomyopathy, Restrictive; Female; Humans; Hydroxychloroquine; Middle Aged

2007